Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...

PARIS, France and TARRYTOWN, NY, USA I 6, 2024 I The European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis ...

The European Medicines Agency has approved Dupixent as the first treatment for eosinophilic esophagitis (EoE) in young children aged one to 11, m ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

Immunology drug Dupixent is seeing very strong, steady growth in atopic dermatitis and asthma, and approvals continue to expend to new indications (nasal polyposis) and younger patients.

After adding both BEV and HEVs to its line-up, MG Motor Philippines is poised to add its first PHEV too. Previewed at the Philippine International Motor Show, the MG HS PHEV will be coming to the ...

The new-generation 2025 MG HS is now on sale in Australia, with substantial updates across design, technology, and powertrain options. The redesigned 2025 HS introduces a new platform and feature set, ...

In a world seemingly obsessed with cost-cutting and shrinkflation it appears MG is one of the few manufacturers still intent on giving you more for your money, not less. Granted, the all-new ZS is a ...

The new electric SUV from MG – spotted being evaluated for Australia last month – promises to set a new pricing benchmark after it was formally launched in its home market in China. According to ...

Eli Lilly (NYSE:LLY) said a Phase 3b study of its drug Ebglyss showed it was able to improve skin and itch in patients with moderate-to-severe atopic dermatitis who had previously been treated ...